ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - July 1959

Decade

Year

Issue

November 2013, Vol 70, No. 11, Pages 1121-1248

In This Issue of JAMA Psychiatry

Highlights

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1121-1123. doi:10.1001/jamapsychiatry.2013.2015
Viewpoint

Bus Therapy: A Problematic Practice in Psychiatry

Abstract Full Text
JAMA Psychiatry. 2013;70(11):1127-1128. doi:10.1001/jamapsychiatry.2013.2824
Art and Images in Psychiatry

In the Realms of the Unreal: Henry Darger

Abstract Full Text
JAMA Psychiatry. 2013;70(11):1125-1126. doi:10.1001/jamapsychiatry.2013.2017
Editorial

Augmenting Obsessive-Compulsive Disorder Treatment: From Brain to Mind

Abstract Full Text
JAMA Psychiatry. 2013;70(11):1129-1131. doi:10.1001/jamapsychiatry.2013.2116

When Depression Doesn’t Lead With Depression

Abstract Full Text
JAMA Psychiatry. 2013;70(11):1131-1132. doi:10.1001/jamapsychiatry.2013.3493
Original Investigation

Prediction of Functional Outcome in Individuals at Clinical High Risk for Psychosis

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1133-1142. doi:10.1001/jamapsychiatry.2013.1909

Carrión et al develop a predictive model of functional (social and role) outcome in a clinical high-risk sample for psychosis.

Functional Dysconnectivity of Corticostriatal Circuitry as a Risk Phenotype for Psychosis

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1143-1151. doi:10.1001/jamapsychiatry.2013.1976

Fornito and colleagues used resting-state functional magnetic resonance imaging to characterize disease-related, risk-related, and symptom-related changes of corticostriatal functional circuitry in patients with first-episode psychosis and their unaffected, first-degree relatives.

Preventing Depressive Relapse and Recurrence in Higher-Risk Cognitive Therapy Responders: A Randomized Trial of Continuation Phase Cognitive Therapy, Fluoxetine, or Matched Pill Placebo

Abstract Full Text
free access has audio
JAMA Psychiatry. 2013;70(11):1152-1160. doi:10.1001/jamapsychiatry.2013.1969

Jarrett and colleagues tested the efficacy of continuation phase cognitive therapy and fluoxetine for relapse prevention in a placebo-controlled randomized trial and compared the durability of prophylaxis after discontinuation of treatments.

Prevention of Depression in At-Risk Adolescents: Longer-term Effects

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1161-1170. doi:10.1001/jamapsychiatry.2013.295

Beardslee et al determine whether the positive effects of a group cognitive-behavioral prevention (CBP) program extended to longer-term (multiyear) follow-up.

Overt Irritability/Anger in Unipolar Major Depressive Episodes: Past and Current Characteristics and Implications for Long-term Course

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1171-1180. doi:10.1001/jamapsychiatry.2013.1957

In an observational, longitudinal study, Judd and coauthors determine the prevalence of overtly expressed irritability/anger and its effect on intake presentation and the long-term course of illness.

Increased Prefrontal Cortex Activity During Negative Emotion Regulation as a Predictor of Depression Symptom Severity Trajectory Over 6 Months

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1181-1189. doi:10.1001/jamapsychiatry.2013.2430

In a 6-month double-blind trial, Heller and coauthors examine changes in the neural circuits involved in emotion regulation resulting from 1 of 2 antidepressant treatments. See also the editorial by Miller.

Cognitive-Behavioral Therapy vs Risperidone for Augmenting Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder: A Randomized Clinical Trial

Abstract Full Text
free access has multimedia
JAMA Psychiatry. 2013;70(11):1190-1199. doi:10.1001/jamapsychiatry.2013.1932

Simpson et al compare the effects of 2 serotonin reuptake inhibitor augmentation strategies, risperidone or cognitive-behavioral therapy consisting of exposure and ritual prevention, vs pill placebo in adults with obsessive-compulsive disorder. See related editorial by Ressler.

Association of Posttraumatic Stress Disorder With Reduced In Vivo Norepinephrine Transporter Availability in the Locus Coeruleus

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1199-1205. doi:10.1001/jamapsychiatry.2013.399

Pietrzak et al performed a cross-sectional positron emission tomography study under resting conditions among 3 study groups (healthy adults, adults exposed to trauma who did not develop posttraumatic stress disorder (PTSD), and adults exposed to trauma who developed PTSD). The [11C]methylreboxetine-binding potential of norepinephrine transporter availability was measured in the locus coeruleus, and PTSD symptom severity was assessed.

Structure of Genetic and Environmental Risk Factors for Symptoms of DSM-IV Borderline Personality Disorder

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1206-1214. doi:10.1001/jamapsychiatry.2013.1944

Reichborn-Kjennerud et al determine the structure of genetic and environmental risk factors for the symptoms of borderline personality disorder.

Identifying Large-Scale Brain Networks in Fragile X Syndrome

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1215-1223. doi:10.1001/jamapsychiatry.2013.247

Hall et al identify large-scale resting-state networks in patients with fragile X syndrome that differ from those in control individuals matched on age, IQ, and severity of behavioral and cognitive symptoms.

A Nationwide Study of the Association Between Celiac Disease and the Risk of Autistic Spectrum Disorders

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1224-1230. doi:10.1001/jamapsychiatry.2013.2048

Ludvigsson and coauthors examine the association between autism spectrum disorders and celiac disease.

Preterm Birth and Mortality and Morbidity: A Population-Based Quasi-experimental Study

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1231-1240. doi:10.1001/jamapsychiatry.2013.2107

D’Onofrio et al estimate the extent to which the associations between early gestational age and offspring mortality and morbidity are the result of confounding factors in a population-based cohort study.

A Novel Approach for Developing and Interpreting Treatment Moderator Profiles in Randomized Clinical Trials

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1241-1247. doi:10.1001/jamapsychiatry.2013.1960

Wallace et al demonstrate a novel exploratory approach to moderation analysis with a sample of 291 adults from a randomized clinical trial that compared an empirically supported psychotherapy and selective serotonin reuptake inhibitor pharmacotherapy as treatments for depression.

Comment & Response

Relapse in Alcohol Use Disorder

Abstract Full Text
JAMA Psychiatry. 2013;70(11):1248. doi:10.1001/jamapsychiatry.2013.2877

Relapse in Alcohol Use Disorder—Reply

Abstract Full Text
JAMA Psychiatry. 2013;70(11):1248. doi:10.1001/jamapsychiatry.2013.2879
JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2013;70(11):1124. doi:10.1001/jamapsychiatry.2013.2013
×